141 results on '"Jacoby, Meagan A."'
Search Results
102. Predicting Autologous Stem Cell Mobilization Failure In Hematologic Malignancies
103. Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial
104. A Phase I Dose Escalation Study Of Oral Bexarotene In Combination With Intravenous Decitabine In Patients With AML
105. Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia
106. Trisomy 8 Is Associated with Increased DNA Double Strand Breaks in Primary Myeloblasts
107. Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes
108. Dysfunctional DNA double‐strand break repair is present in a subset of primary t‐aml myeloblasts
109. A Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplant
110. Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,
111. Dysfunctional DNA Double-Strand Break Repair Is Present in a Subset of Primary t-AML/t-MDS Myeloblasts
112. Dysfunctional Double-Strand DNA Break Repair In Primary t-AML/t-MDS Myeloblasts.
113. BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.
114. Systematic Mutagenesis of the Murine Gammaherpesvirus 68 M2 Protein Identifies Domains Important for Chronic Infection
115. Murine Gammaherpesvirus 68 Infection Is Associated with Lymphoproliferative Disease and Lymphoma in BALB β2 Microglobulin-Deficient Mice
116. The Murine Gammaherpesvirus 68 M2 Gene Is Required for Efficient Reactivation from Latently Infected B Cells
117. Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection
118. Disruption of the M2 Gene of Murine Gammaherpesvirus 68 Alters Splenic Latency following Intranasal, but Not Intraperitoneal, Inoculation
119. The Murine Gammaherpesvirus 68 v-Cyclin Gene Is an Oncogene That Promotes Cell Cycle Progression in Primary Lymphocytes
120. Quantifying Serum Antiplague Antibody with a Fiber-Optic Biosensor
121. Effectiveness of protein A for antibody immobilization for a fiber optic biosensor
122. Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
123. A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.
124. The authors reply.
125. Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant
126. A Pilot Study of CX-01 with Azacitidine for Treatment of Hypomethylating Agent-Refractory AML and MDS
127. Persistent Molecular Disease in Adult Patients With AML Evaluated With Whole-Exome and Targeted Error-Corrected DNA Sequencing.
128. Donor-to-Recipient Weight Ratio Is Independently Associated with CD34+Yield in Healthy Donors Undergoing Peripheral Blood Stem Cell Collection for Allogeneic Transplantation
129. BRCA1and BRCA2Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.
130. Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
131. A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
132. Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.
133. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
134. Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.
135. Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS.
136. A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival.
137. Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation.
138. Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia.
139. Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.
140. Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
141. Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation Sequencing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.